Avanos Medical files 8-K for Q4 and FY2022 results; press release text not provided in this filing excerpt

AVANOS MEDICAL, INC.

2022-FY EPS reported $1.07 revenue$820,000,000

Filing reports results for three months and year ended December 31, 2022.
Press release attached as Exhibit 99.1 but not included in the provided text.
No specific financial figures (revenue, EPS, guidance) available to summarize.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AVANOS MEDICAL, INC. reported financial results for the three months and year ended December 31, 2022.

Period: the three months and year ended December 31, 2022
Result: reported results

Exact text from the filing

The Company announced its results of operations for the three months and year ended December 31, 2022 in a press release dated February 21, 2023 that is attached and incorporated herein by reference as Exhibit 99.1.

View on SEC.gov

Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-23-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.